Furthermore, shock-related end-organ function impairment may affect oral P2Y12 inhibitor metabolism, but cangrelor would not be affected by liver or kidney failure owing to its plasmatic metabolism [14]. The gene discussed is P2RY12; the disease is kidney failure.